M42, a global health leader powered by technology, AI and genomics, has announced a strategic partnership with 10X Health (USA) and REVIV Global (UK) to launch 10XREVIV, a pioneering venture set to ...

Mahesh Babu MG stands out as a visionary in SAP supply chain optimization and a guiding force behind the global SAP ...

A new consensus report on the management of type 1 diabetes in adults was presented recently at the European Association for ...

Key market opportunities in the AI-powered rare disease diagnosis domain include leveraging AI for personalized medicine, ...

The AI microscopy market is driven by personalized medicine, precision therapy demand, and real-time image advancements.

Working with the same tumor slices that pathologists use to diagnose and guide treatment of patients, however, Carstens can ...

To address the growing issue of human-tiger conflict, the platform includes a three-level warning and control system, with ...

Mucopolysaccharidosis type II or Hunter’s syndrome is a rare, X-linked genetic lysosomal storage disorder, which results in multiorgan dysfunction and accumulation of glycosaminoglycans in various ...

A new consumer research study from Levanta, the leading affiliate marketing platform for brands and creators, reveals that while artificial intelligence has transformed how people research products, ...

Immuron receives U.S. Food and Drug administration (FDA) approval for IMM-529 Investigational New Drug (IND) application and clinical study may proceed FDA assigned an IND number (032095) for the ...

In the field of paediatrics, the concept of normal (ie, typical)—in contrast to different, special, deviant, delayed, or ...

New data provide key mechanistic insights into how TG4050 induces and sustains potent, CD8+ T cell responses in operable HNSCC[*] ...